Vanderbilt Ingram Cancer Center
Probing DNA damage repair
Jun. 18, 2020—After discovering a new mechanism for DNA damage repair last year, Vanderbilt biochemists now provide direct evidence for how it works.
Career enhancement funding opportunity: VICC SPORE in Breast Cancer
Jun. 11, 2020—The VICC SPORE in Breast Cancer announces a Career Enhancement Program funding opportunity that aims to attract, develop and mentor promising basic, translational and population-based research scientists, including physician scientists, into breast cancer research.
Developmental research funding opportunity: VICC SPORE in Breast Cancer
Jun. 11, 2020—The VICC SPORE in Breast Cancer announces a Developmental Research Program pilot funding opportunity focused on catalyzing innovative and transformative breast cancer-related projects that promote discoveries in basic and translational research focused on metastatic disease.
Study finds AI can categorize cancer risk of lung nodules
May. 7, 2020—Computed tomography scans for people at risk for lung cancer lead to earlier diagnoses and improve survival rates, but they can also lead to overtreatment when suspicious nodules turn out to be benign.
Study tracks genomics of lung tumor behavior
Apr. 13, 2020—A study by Vanderbilt researchers has identified genomic alterations in early stage adenocarcinomas of the lung that may indicate whether the lesions develop into aggressive tumors.
Triple-negative breast cancer drug therapy shows promise
Mar. 12, 2020—Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation.
Vanderbilt-Ingram Cancer Center offers transformative cancer research funding opportunity
Mar. 6, 2020—The Vanderbilt-Ingram Cancer Center announces a funding opportunity to support innovative cancer-related projects in need of preliminary data. The goal of this award is to provide funding to support paradigm-shifting, practice-improving or policy-changing research.
One-two punch for cancer
Mar. 5, 2020—A drug combination effectively killed aggressive blood cancers in cell and animal models; now it’s being tested in patients.
Breast cancer study may help predict treatment response
Feb. 27, 2020—Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.
Protein research seeks to induce tumor regression
Jan. 29, 2020—MYC is a family of three related proteins that are overexpressed in cancer and which contribute to an estimated 100,000 cancer deaths annually in the United States. Understanding how MYC works could lead to the development of new drugs that can effectively block MYC and stop many cancers in their tracks.
Genetic screen in worms reveals critical step in insulin synthesis
Dec. 4, 2019—The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.
High fiber, yogurt diet associated with lower lung cancer risk
Oct. 28, 2019—A diet high in fiber and yogurt is associated with a reduced risk for lung cancer, according to a study by Vanderbilt University Medical Center researchers.